[Ivermectin inhibits activation of Kupffer cells induced by lipopolysaccharide toxin]

A V Viktorov1

  • 1Research Biological Center Pharmbiomed, Central Research Institute of Epidemiology, Ministry of Health of the Russian Federation, Moscow.

Insights

Ivermectin inhibits inflammatory responses in rat Kupffer cells stimulated by lipopolysaccharide (LPS). This effect, mediated by chloride channels, reduces the secretion of inflammatory substances like TNF-alpha and NO.

Area of Science:

  • Immunology
  • Pharmacology

Context:

  • Liver macrophages (Kupffer cells) are key in inflammatory responses.
  • Lipopolysaccharide (LPS) from Gram-negative bacteria triggers these responses.

Purpose:

  • To investigate how ivermectin modulates LPS-induced Kupffer cell activation.
  • To elucidate the mechanism of ivermectin's anti-inflammatory action in Kupffer cells.

Summary:

  • Ivermectin alone did not affect Kupffer cell function.
  • Pre-treatment with ivermectin significantly suppressed LPS-induced secretion of tumor necrosis factor-alpha (TNF-alpha), nitric oxide (NO), and prostaglandin E2.
  • Ivermectin also reduced LPS-stimulated intracellular calcium ion increases.
  • The inhibitory effects of ivermectin were dependent on extracellular chloride anions.

Impact:

  • Ivermectin's action may involve glycine-gated chloride receptors/channels on Kupffer cells.
  • This mechanism suggests a potential therapeutic role for ivermectin in mitigating inflammatory conditions associated with Gram-negative bacterial infections.